These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39347189)

  • 1. Epithelioid Inflammatory Myofibroblastic Sarcoma: A Report of a Rare Case.
    Ronanki V; Tejeswini V; Venkata Renuka I; Raheema S; S K Kanth B
    Cureus; 2024 Aug; 16(8):e68184. PubMed ID: 39347189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review.
    Singh P; Nambirajan A; Gaur MK; Raj R; Kumar S; Malik PS; Jain D
    J Pathol Transl Med; 2022 Jul; 56(4):231-237. PubMed ID: 35843628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.
    Li M; Xing R; Huang J; Shi C; Wei C; Wang H
    Front Oncol; 2023; 13():1084456. PubMed ID: 37035183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement.
    Zheng Y; Zhao F; Ren Y; Xue Y; Yan B; Huang C
    Front Pharmacol; 2024; 15():1401428. PubMed ID: 39144623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.
    Fu X; Jiang J; Tian XY; Li Z
    Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
    Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
    Front Oncol; 2022; 12():761558. PubMed ID: 35237506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
    Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
    J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma.
    Fadl A; Feldman AL
    J Hematop; 2023 Jun; 16(2):125-126. PubMed ID: 37398940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal epithelioid inflammatory myofibroblastic sarcoma with the
    Pan T; Sun X; Wu X; Tang F; Zhou X; Wang Q; Chen S
    Respirol Case Rep; 2024 Jan; 12(1):e01267. PubMed ID: 38107408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.
    Du X; Gao Y; Zhao H; Li B; Xue W; Wang D
    Oncol Lett; 2018 Jun; 15(6):9317-9326. PubMed ID: 29805657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
    Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
    Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review.
    Dou W; Guan Y; Liu T; Zheng H; Feng S; Wu Y; Wang X; Liu Z
    Front Oncol; 2023; 13():1212529. PubMed ID: 37841422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report.
    Xu X; Li H; Peng K; Yu Y; Chen L; Fang Y; Sun Y; Hou Y; Liu T
    Oncol Lett; 2019 Feb; 17(2):2370-2376. PubMed ID: 30675302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelioid Inflammatory Myofibroblastic Sarcoma With Poor Response to Crizotinib: A Case Report.
    Aminimoghaddam S; Pourali R
    Clin Med Insights Case Rep; 2023; 16():11795476231163954. PubMed ID: 37841512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelioid inflammatory myofibroblastic sarcoma: a case report.
    Sarmiento DE; Clevenger JA; Masters GA; Bauer TL; Nam BT
    J Thorac Dis; 2015 Oct; 7(10):E513-6. PubMed ID: 26623133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crizotinib in ALK
    Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion.
    Li X; Zheng J; Li X; Chen Y; Liu K; Li F; Lu Z
    Front Oncol; 2023; 13():1252221. PubMed ID: 37869075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic epithelioid inflammatory myofibroblastic sarcoma: a rare and aggressive disease with case report and literature review.
    Yang L; Li P; Liu R; Feng B; Mao H; Tang X; Yang G
    Discov Oncol; 2024 Sep; 15(1):484. PubMed ID: 39331206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.